Rekvina Laboratories Limited, a specialized pharmaceutical company focused on the manufacturing and marketing of therapeutic formulations, has announced the induction of Jay Chintan Patel into its Board of Directors. Appointed as an Additional Non-Executive Independent Director, Patel brings a fresh perspective to the company’s corporate governance framework. His appointment, effective in late January 2026, aligns with the company’s efforts to strengthen independent oversight as it navigates the competitive pharmaceutical landscape and evolving compliance requirements under the SEBI (LODR) Regulations.
